Biologics Supplier for Medspas and Dermatology in Milwaukee, WI

Account verification for medspas and physician-supervised practices

Because sales are limited to licensed clinics, medspas under physician supervision, and physicians, Precision Biologics verifies every account against an NPI number before it can order. For a medspa, the account is generally tied to the supervising physician's or practice's NPI, which mirrors how most Milwaukee-area aesthetic practices already structure vendor relationships for procedural supplies.

Documentation before adding a new line

A dermatology or aesthetic practice adding a new biologics line typically wants to see the donor eligibility and screening summary, a certificate of analysis for the specific lot, and, for exosome formats, a full ingredient disclosure. These records are available to verified accounts and can be reviewed before any order is placed.

• Donor eligibility and screening summary
• Lot-specific certificate of analysis
• Full ingredient disclosure for lyophilized exosome formats
• Storage and handling instructions for the format ordered

Shipping to Wisconsin practices

Cryopreserved Wharton's jelly formats ship overnight on dry ice in validated containers and should be inspected against the packing slip and lot number as soon as they arrive. Lyophilized exosome formats are shelf-stable under normal storage and ship without the same cold-chain requirements, though both arrive with lot-specific documentation that a practice can file alongside patient records for traceability.

Medical director review and regulatory verification

A supervising physician or medical director should review and sign off on any new product line before it's offered in a Milwaukee medspa, and the practice should separately confirm its standing with the Wisconsin Medical Examining Board. FDA has stated there are no FDA-approved exosome products, so any claims about what an exosome product accomplishes clinically should be reviewed with counsel rather than assumed from supplier marketing. Precision Biologics supports account setup with documentation-focused calls between medical directors but does not advise on clinical use.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.